Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
2024 · Journal of Hematology & Oncology · 135 citations
https://doi.org/10.1186/s13045-024-01581-2
Y
Yijun Wu
Henan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
373
Citations
9
h-index
9
i10-index
Yijun Wu is an academic researcher from Henan University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cholangiocarcinoma and Gallbladder Cancer Studies & Gallbladder and Bile Duct Disorders. The author has an h-index of 9, co-authored 24 publications.
ORCID: 0000-0003-2055-3254Papers by this author
worksPrognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China
2021 · BMC Cancer · 51 citations
https://doi.org/10.1186/s12885-021-09035-5
Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI
2023 · BMC Cancer · 0 citations
https://doi.org/10.1186/s12885-023-11096-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat